Revitalizing FDA’s Office Of Regulatory Affairs Means ‘Buying’ Some Expertise
This article was originally published in The Gray Sheet
Executive Summary
After years of shrinking resources and workforce attrition, FDA's Office of Regulatory Affairs plans to aggressively recruit new staff to meet the emerging challenges of more complex products and overseas manufacturing
You may also be interested in...
FDA’s Office Of Regulatory Affairs Loses Two Top Officials, Including Chief
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity
FDA’s Office Of Regulatory Affairs Loses Two Top Officials, Including Chief
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing the agency's inspections and enforcement activity
Senate Budget Bill Responds To Outcry, Adds $375 Million To FDA
Recent calls to significantly increase FDA funding are starting to yield fruit, evidenced by Senate passage March 14 of $375 million in additional funds for the agency as part of the FY 2009 budget package for the U.S. government